Highlights Alfresa Holdings Corporation

Equities

2784

JP3126340003

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-07-05 am EDT			5-day change	1st Jan Change
2,142 ^JPY	-1.22%		-2.48%	-10.62%

Jun. 06	Healios Enters Alliance, Bond Purchase Deal with Alfresa	MT
May. 28	Alfresa Holdings' Subsidiary Forms Pact with National Center for Child Health and Development to Supply Somatic Stem Cell Materials	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Healios Enters Alliance, Bond Purchase Deal with Alfresa	Jun. 05	MT
Alfresa Holdings' Subsidiary Forms Pact with National Center for Child Health and Development to Supply Somatic Stem Cell Materials	May. 27	MT
Alfresa's Fiscal 2023 Attributable Profit Rises 15% on Net Sales Growth	May. 16	MT
Alfresa Holdings Corporation Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024	Apr. 30	CI
Alfresa Holdings Corporation Revises Consolidated Earnings Guidance for the Full Year Ending March 31, 2024	Apr. 30	CI
Final dividend	Mar. 27	FA
Anniversary bonus dividend	Mar. 27	FA
Alfresa Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 08	CI
Alfresa Holdings Corporation Provides Commemorative Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 08	CI
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024	Feb. 08	CI
Alfresa Holdings Corporation Revises Consolidated Earnings Guidance for the First Half Ended September 30, 2023 and Fiscal Year March 31, 2024	23-10-31	CI
Alfresa Holdings Completes 35 Billion Yen Share Buyback program	23-10-03	MT
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023.	23-10-03	CI
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023.	23-10-02	CI
Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2023, has closed with 15,201,200 shares, representing 7.65% for ¥34,999.80 million.	23-10-01	CI
Ex-dividend day for interim dividend	23-09-27	FA
Anniversary bonus dividend	23-09-27	FA
Alfresa unit Cell Resources Partners with Miltenyi Biotec to Advance Cell Culture Automation in Gene Cell Therapy Market	23-08-22	MT
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024	23-08-08	CI
Alfresa Holdings Corporation Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending March 31, 2023	23-08-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Alfresa Holdings Corporation

Equities

2784

JP3126340003

Highlights

Filters